Cyclacel Pharmaceuti (CYCC)

$16.04 -1.11 (-6.47%)
Market Cap 25.42M
Revenue (ttm) 40,000.00
Net Income (ttm) -11.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28,025.00%
Debt to Equity Ratio 0.00
Volume 463,400
Avg Vol 2,259,275
Day's Range N/A - N/A
Shares Out 1.59M
Stochastic %K 75%
Beta 0.03
Analysts Strong Buy
Price Target $1.00

Company Profile

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Industry: Biotechnology
Sector: Healthcare
Phone: 60 9 08517 7330
Address:
Level 10, Tower 11 Avenue 5, No. 8 Jalan Kerinchi, Kuala Lumpur, Malaysia
ChartChartist
ChartChartist Jul. 27 at 1:52 AM
$SOAR bought to bust new highs $TZUP wants 16 $CYCC still flagging $ OLB a hot couple trades for Monday to fund other plays. Its off bottom and has momo
0 · Reply
JdNews
JdNews Jul. 26 at 7:34 PM
$CYCC This was a no brainer. Going to market in September. This will gain so much. Buy every low you see
1 · Reply
Goosem4n
Goosem4n Jul. 26 at 1:13 AM
$CYCC 🤞😊🤞
0 · Reply
bahjatbern
bahjatbern Jul. 25 at 10:17 PM
$CYCC i think this stock with this price is a steal , pre RS were playing between 1.5 $ /4 $ , so it should be now with 64 $ till 24 $ range ??agree ?
0 · Reply
MarkTheGenius
MarkTheGenius Jul. 25 at 9:26 PM
$CYCC $16 is not a bad close. Took it's pounding and hung in there. Well done Bulls.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jul. 25 at 8:29 PM
$IXHL $CYCC $BTOG $SAIH $ZEPP
0 · Reply
007lala
007lala Jul. 25 at 8:11 PM
$CYCC fking googoooggoogogogoogo
0 · Reply
007lala
007lala Jul. 25 at 7:54 PM
$CYCC the is not my color.
0 · Reply
007lala
007lala Jul. 25 at 7:52 PM
$CYCC short calisse ton camp!
0 · Reply
007lala
007lala Jul. 25 at 7:48 PM
$CYCC calis encore
0 · Reply
Latest News on CYCC
Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?

Jul 15, 2025, 12:17 PM EDT - 11 days ago

Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?

CYCCP

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

Jul 7, 2025, 6:00 AM EDT - 20 days ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

CYCCP

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Jul 7, 2025, 6:00 AM EDT - 20 days ago

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

CYCCP

Cyclacel Pharmaceuticals Announces Stock Split

Jul 2, 2025, 9:00 AM EDT - 24 days ago

Cyclacel Pharmaceuticals Announces Stock Split

CYCCP

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

Jun 20, 2025, 4:30 PM EDT - 5 weeks ago

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCCP

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Jun 3, 2025, 4:15 PM EDT - 7 weeks ago

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

CYCCP

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 15, 2025, 12:50 AM EDT - 2 months ago

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

CYCCP

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT

May 7, 2025, 9:00 AM EDT - 2 months ago

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT

CYCCP

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN.

May 6, 2025, 6:00 AM EDT - 2 months ago

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN.

CYCCP

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Apr 2, 2025, 4:05 PM EDT - 4 months ago

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

CYCCP

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock

Mar 24, 2025, 7:30 AM EDT - 4 months ago

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock

CYCCP

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

Feb 27, 2025, 1:38 PM EST - 5 months ago

Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

CYCCP

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

Jan 3, 2025, 9:01 AM EST - 7 months ago

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

CYCCP

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs

Dec 5, 2024, 4:05 PM EST - 8 months ago

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs

CYCCP

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

Nov 14, 2024, 4:15 PM EST - 9 months ago

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds

CYCCP

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Nov 13, 2024, 12:22 PM EST - 9 months ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

CYCCP

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Nov 12, 2024, 4:45 PM EST - 9 months ago

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

CYCCP

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

Oct 24, 2024, 9:15 AM EDT - 9 months ago

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule

CYCCP

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

Oct 23, 2024, 9:15 AM EDT - 9 months ago

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

CYCCP

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

Oct 9, 2024, 9:15 AM EDT - 10 months ago

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium

CYCCP

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

Sep 25, 2024, 9:15 AM EDT - 10 months ago

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

CYCCP

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 9:15 AM EDT - 11 months ago

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

CYCCP

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

Sep 3, 2024, 9:15 AM EDT - 11 months ago

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter

CYCCP

Cyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 8:18 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call Transcript

CYCCP

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

Aug 7, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results

CYCCP

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

Jun 26, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

CYCCP

Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

Jun 4, 2024, 8:00 AM EDT - 1 year ago

Cyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting

CYCCP

Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:08 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript

CYCCP

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

May 8, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

CYCCP

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

May 2, 2024, 4:30 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

CYCCP

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CYCCP

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer

Apr 1, 2024, 9:15 AM EDT - 1 year ago

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer

CYCCP

Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript

Mar 19, 2024, 6:09 PM EDT - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript

CYCCP

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 19, 2024, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

CYCCP

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

Mar 13, 2024, 4:05 PM EDT - 1 year ago

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

CYCCP

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Mar 7, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

CYCCP

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

Mar 6, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

CYCCP

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

Feb 20, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

CYCCP

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

Jan 30, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

CYCCP

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Jan 8, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

CYCCP

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

Jan 2, 2024, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

CYCCP

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

Dec 22, 2023, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules

CYCCP

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

Dec 18, 2023, 9:00 AM EST - 1 year ago

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions

CYCCP

Cyclacel Pharmaceuticals Announces Reverse Stock Split

Dec 12, 2023, 4:05 PM EST - 1 year ago

Cyclacel Pharmaceuticals Announces Reverse Stock Split

CYCCP

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

Nov 30, 2023, 9:15 AM EST - 1 year ago

Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC

CYCCP

Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

Nov 28, 2023, 5:15 PM EST - 1 year ago

Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q

CYCCP

Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 7:32 PM EST - 1 year ago

Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2023 Earnings Call Transcript

CYCCP

Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results

Nov 7, 2023, 9:15 AM EST - 1 year ago

Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Results

CYCCP

Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results

Aug 3, 2023, 9:15 AM EDT - 2 years ago

Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results

CYCCP

Cyclacel Pharmaceuticals Inc. (CYCC) Q1 2023 Earnings Call Transcript

May 11, 2023, 7:59 PM EDT - 2 years ago

Cyclacel Pharmaceuticals Inc. (CYCC) Q1 2023 Earnings Call Transcript

CYCCP

ChartChartist
ChartChartist Jul. 27 at 1:52 AM
$SOAR bought to bust new highs $TZUP wants 16 $CYCC still flagging $ OLB a hot couple trades for Monday to fund other plays. Its off bottom and has momo
0 · Reply
JdNews
JdNews Jul. 26 at 7:34 PM
$CYCC This was a no brainer. Going to market in September. This will gain so much. Buy every low you see
1 · Reply
Goosem4n
Goosem4n Jul. 26 at 1:13 AM
$CYCC 🤞😊🤞
0 · Reply
bahjatbern
bahjatbern Jul. 25 at 10:17 PM
$CYCC i think this stock with this price is a steal , pre RS were playing between 1.5 $ /4 $ , so it should be now with 64 $ till 24 $ range ??agree ?
0 · Reply
MarkTheGenius
MarkTheGenius Jul. 25 at 9:26 PM
$CYCC $16 is not a bad close. Took it's pounding and hung in there. Well done Bulls.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jul. 25 at 8:29 PM
$IXHL $CYCC $BTOG $SAIH $ZEPP
0 · Reply
007lala
007lala Jul. 25 at 8:11 PM
$CYCC fking googoooggoogogogoogo
0 · Reply
007lala
007lala Jul. 25 at 7:54 PM
$CYCC the is not my color.
0 · Reply
007lala
007lala Jul. 25 at 7:52 PM
$CYCC short calisse ton camp!
0 · Reply
007lala
007lala Jul. 25 at 7:48 PM
$CYCC calis encore
0 · Reply
1Smith
1Smith Jul. 25 at 7:44 PM
$CYCC Monday. 👀 ⬆️
0 · Reply
JdNews
JdNews Jul. 25 at 6:09 PM
$CYCC Listen this a month to back and forth. Buy back lower. But have shares into the next dsy. This will blow up to 50$. Msyje 100$. I’m thinkin, cuz. Drug goes crazy by September. I’m thinking August has a run before .
0 · Reply
JdNews
JdNews Jul. 25 at 5:44 PM
$CYCC This might break before it actually goes to market. So many stocks I’ve been in will short squeeze before it actually happens on paper. Buy back all you can
0 · Reply
JdNews
JdNews Jul. 25 at 5:41 PM
$CYCC Nice gain to more than I hold. Sold high /. And will buy back lower. Will do this til September. Then it goes to market
0 · Reply
bahjatbern
bahjatbern Jul. 25 at 3:36 PM
$CYCC Is it over ?
1 · Reply
joe_trump
joe_trump Jul. 25 at 3:08 PM
$CYCC will drop to $10-12 on Monday.
1 · Reply
phupharm
phupharm Jul. 25 at 2:27 PM
$CYCC
0 · Reply
phupharm
phupharm Jul. 25 at 2:21 PM
$CYCC it’s creeping up on low volume.
0 · Reply
Sw1ngb0t
Sw1ngb0t Jul. 25 at 1:38 PM
$IXHL $ATNF $BTOG $CYCC $ZEPP lol I switched from ATNF to IXHL last night... what a bummer...could have quadrupled my account in one day... baby steps
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 25 at 1:31 PM
$ABP $0.35 so far. $1 next leg. went to $13 last run. Collaboration with AstraZeneca and $1.75B from Celtrion. FDA news coming. boom boom like $LHAI and $CYCC
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 25 at 1:23 PM
$ABP $LHAI $CYCC
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 25 at 1:06 PM
$ABP $LHAI $CYCC
0 · Reply